GlassScriptPhysician profile
George W Moore
NPI 1588604110
$54,994.62
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $2,449 · 2021: $1,511.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40,085.11 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $10,770.12 | 2019-2021 | |
| Novo Nordisk INC | $590.23 | 2019-2021 | |
| Antares Pharma, INC. | $476.38 | 2019-2021 | |
| Amarin Pharma, INC. | $407.89 | 2019-2021 | |
| Dexcom, INC. | $307.67 | 2019-2021 | |
| Lilly USA, LLC | $265.76 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $236.36 | 2019-2020 | |
| Ibsa Pharma INC. | $181.59 | 2019-2020 | |
| Abbvie INC. | $157.09 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $112.80 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $103.36 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $99.46 | 2019-2021 | |
| Corcept Therapeutics | $87.64 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $83.53 | 2019-2020 | |
| Esperion Therapeutics, INC. | $73.32 | 2020 | |
| Lifescan, INC. | $73.31 | 2020 | |
| Insulet Corporation | $72.78 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $63.41 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $54.96 | 2019 | |
| Alfasigma USA, INC. | $51.75 | 2020-2021 | |
| Vistapharm, INC. | $48.93 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $47.92 | 2021 | |
| Medicure Pharma INC. | $42.62 | 2021 | |
| Radius Health, INC. | $38.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.89 | 2019-2021 | |
| Companion Medical, INC. | $28.50 | 2019 | |
| Medtronic Minimed, INC. | $26.60 | 2020 | |
| Zealand Pharma US, INC. | $22.82 | 2021 | |
| Ferring Pharmaceuticals INC. | $22.16 | 2019 | |
| Mannkind Corporation | $20.51 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.40 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $14.23 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.67 | 2020 | |
| Pfizer INC. | $12.30 | 2021 | |
| Acella Pharmaceuticals, LLC | $11.18 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.